US ENERGY CORP 8-K

What Happened
U.S. Energy Corp. announced on April 17, 2026 that it entered into a Second Amendment to its January 5, 2022 credit agreement with Firstbank Southwest (as administrative agent) and the lenders. The amendment increases the borrowing base from $10.0 million to $20.0 million, sets the interest margin at a fixed 2.00% above the alternate base rate (ABR), suspends testing of financial covenants until the quarter ending March 31, 2027, and keeps revolving availability through May 31, 2029. The company issued a related press release on April 20, 2026.

Key Details

• Second Amendment date: April 17, 2026; press release furnished April 20, 2026.
• Borrowing base increased from $10,000,000 to $20,000,000.
• Interest rate: ABR (greater of prime or Fed funds + 0.50%) + 2.00% margin; +2.00% penalty margin if certain defaults occur. Interest paid quarterly.
• Revolving loans can be borrowed, repaid and re-borrowed until May 31, 2029; $2,500,000 outstanding as of the 8‑K date.
• Commitment fee: 0.50% on unused portion of the borrowing base, payable quarterly.
• Financial covenants (total debt to EBITDAX ≤ 3:1; current ratio ≥ 1:1) are suspended for testing until the quarter ending March 31, 2027.
• Mandatory repayment triggers and customary covenants remain (including restrictions on indebtedness, liens, dividends, and transactions with affiliates).
• The company has suspended further use of its Oct. 9, 2025 common stock purchase agreement with Roth Principal Investments, LLC after securing this amendment and proceeds from its March 2026 equity offering.

Why It Matters
This amendment materially improves U.S. Energy’s near‑term liquidity and financing flexibility by doubling its borrowing base and locking in credit availability through 2029, while delaying covenant testing until 2027. For investors, the added liquidity plus recent equity proceeds are intended to fund Phase 1 construction of the company’s planned Big Sky Carbon Hub—targeting initial commercial operations (helium sales and carbon management) in Q1 2027—reducing near‑term dilution risk from the previously available equity line. Regulatory milestones (EPA MRV reviews and Section 45Q tax credit considerations) and a targeted long‑term helium offtake remain key operational catalysts noted by the company.